MedTrace Logo

Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine

NCT05584735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2025-07-31

No results posted yet for this study

Summary

This study will evaluate the effect of the microorganisms in the gut on how well the flu or COVID-19 vaccine works in people who have a weakened immune system due to inflammatory bowel disease. Participants can expect to be in the study for up to 65 days.

Conditions

  • Inflammatory Bowel Diseases

Interventions

BIOLOGICAL

Influenza vaccine

Observe effects of flu vaccine on microbiome

BIOLOGICAL

COVID-19 vaccine

Observe effects of COVID-19 vaccine on microbiome

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Freddy Caldera, DO, MS · University of Wisconsin, Madison

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-03
Primary Completion
2025-03-20
Completion
2025-03-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05584735 on ClinicalTrials.gov